MedTrace Logo

Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma

NCT04744935 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-03-24

No results posted yet for this study

Summary

Optical coherence tomography guided laser treatment of basal cell carcinoma

Conditions

Interventions

DEVICE

1064 nm long-pulse Nd:YAG laser

BCC lesion will be treated with long-pulse 1064 laser, with surface temperature monitored by infrared camera.

Sponsors & Collaborators

  • Christopher Zachary

    lead OTHER

Principal Investigators

  • Christopher Zachary, MBBS FRCP · University of California, Irvine

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-13
Primary Completion
2027-02-17
Completion
2027-02-17
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04744935 on ClinicalTrials.gov